Target Name: BEX2
NCBI ID: G84707
Review Report on BEX2 Target / Biomarker Content of Review Report on BEX2 Target / Biomarker
BEX2
Other Name(s): brain expressed X-linked 2 | BEX2 variant 3 | Brain expressed X-linked 2 | Brain expressed X-linked 2, transcript variant 3 | Brain expressed, X-linked 2 | hBex2 | Protein BEX2 | OTTHUMP00000023736 | Brain-expressed X-linked protein 2 | BEX1 | brain-expressed X-linked protein 2 | X-linked protein | OTTHUMP00000023735 | DJ79P11.1 | BEX2_HUMAN | Protein BEX2 (isoform 3)

BEX2: A Brain-Expressed X-linked 2 Protein as a Potential Drug Target and Biomarker

Introduction

Brain-expressed X-linked (BEX2) protein is a highly conserved non-coding RNA molecule that plays a critical role in various cellular processes, including neuronal differentiation, synaptic plasticity, and neurotransmission. BEX2 is expressed in almost all brain regions and is involved in regulating a wide range of neural functions. In recent years, researchers have conducted in-depth studies on the function and mechanism of BEX2, and also discovered the important role of BEX2 in a variety of neurological diseases. This article will introduce BEX2 as a potential drug target and biomarker, providing new ideas and theoretical basis for related research.

Biological functions of BEX2

BEX2 is a long non-coding RNA molecule, and its coding region contains multiple transcription factor binding sites. These sites may be closely related to biological processes such as transcription and splicing of BEX2. BEX2 plays an important role in a variety of biological processes, including:

1. Regulate neuronal differentiation: BEX2 plays a key role in the process of neuronal differentiation. Studies have shown that BEX2 can promote the differentiation of neural stem cells into mature neurons and maintain the stability of neural networks by regulating neural cell fate.

2. Participate in neuronal synapse formation: BEX2 participates in the synapse formation process between neurons. Studies have found that BEX2 can bind to the synaptic vesicle membrane between neurons and is closely related to the release and reuptake process of neurotransmitters.

3. Regulate synaptic communication between neurons: BEX2 participates in the process of synaptic communication between neurons. Studies have shown that BEX2 can bind to receptors on the postsynaptic membrane, thereby affecting the release and reuptake of neurotransmitters and regulating synaptic communication between neurons.

4. Participate in neuronal metabolism: BEX2 plays an important role in the metabolic process of neurons. Studies have shown that BEX2 can participate in the energy metabolism of neurons and is related to the regulation of neuronal apoptosis.

Pharmacological significance of BEX2

As a new drug target, BEX2 has broad application prospects. Currently, a variety of drugs that inhibit BEX2 expression have entered clinical research. For example, BEX2 inhibitors have emerged as a new class of drugs to treat neurological diseases. These drugs reduce abnormal proliferation and apoptosis of neurons by inhibiting the expression of BEX2, thereby improving neuronal function.

In addition, BEX2 can also be used as a biomarker to detect the progression and treatment effect of neurological diseases. For example, by measuring the expression levels of BEX2, the extent of neuronal damage can be assessed and thus the effectiveness of treatment.

Pathological significance of BEX2

BEX2 also plays an important role in neurological diseases. Studies have shown that abnormal expression of BEX2 is closely related to the occurrence and development of a variety of neurological diseases, including neurodegenerative diseases, neuropsychiatric diseases, and neurodevelopmental diseases.

For example, overexpression of BEX2 is associated with Alzheimer's disease. Research has found that BEX2 is overexpressed in the brains of Alzheimer's disease patients and is associated with neuronal damage and reduced neuron number.

Clinical applications of BEX2

As a new drug target, BEX2 has broad application prospects. Currently, a variety of drugs that inhibit BEX2 expression have entered clinical research. For example, BEX2 inhibitors have emerged as a new class of drugs to treat neurological diseases. These drugs reduce abnormal proliferation and apoptosis of neurons by inhibiting the expression of BEX2, thereby improving neuronal function.

In addition, BEX2 can also be used as a biomarker to detect the progression and treatment effect of neurological diseases. For example, by measuring the expression levels of BEX2, the extent of neuronal damage can be assessed and thus the effectiveness of treatment.

in conclusion

BEX2 is an important protein involved in the biological processes of neurons. In recent years, researchers studying BEX2 have found that BEX2 plays an important role in neurological diseases and serves as a potential drug target. By inhibiting the expression of BEX2, abnormal proliferation and apoptosis of neurons can be reduced, thereby improving neuronal function. BEX2 can also serve as a biomarker for detecting the progression of neurological diseases and the effectiveness of treatment. Therefore, BEX2, as a new drug target, has broad application prospects.

Protein Name: Brain Expressed X-linked 2

Functions: Regulator of mitochondrial apoptosis and G1 cell cycle in breast cancer. Protects the breast cancer cells against mitochondrial apoptosis and this effect is mediated through the modulation of BCL2 protein family, which involves the positive regulation of anti-apoptotic member BCL2 and the negative regulation of pro-apoptotic members BAD, BAK1 and PUMA. Required for the normal cell cycle progression during G1 in breast cancer cells through the regulation of CCND1 and CDKN1A. Regulates the level of PP2A regulatory subunit B and PP2A phosphatase activity

The "BEX2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BEX2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

BEX3 | BEX4 | BEX5 | BFAR | BFSP1 | BFSP2 | BFSP2-AS1 | BGLAP | BGLT3 | BGN | BHC complex | BHLHA15 | BHLHA9 | BHLHE22 | BHLHE22-AS1 | BHLHE23 | BHLHE40 | BHLHE40-AS1 | BHLHE41 | BHMT | BHMT2 | BICC1 | BICD1 | BICD2 | BICDL1 | BICDL2 | BICRA | BICRAL | BID | BIK | BIN1 | BIN2 | BIN3 | BIN3-IT1 | Biogenesis of lysosome-related organelles complex-1 | BIRC2 | BIRC3 | BIRC5 | BIRC6 | BIRC7 | BIRC8 | BISPR | BIVM | BIVM-ERCC5 | BLACAT1 | BLACE | BLCAP | BLID | BLK | BLM | BLMH | BLNK | BLOC-1 (biogenesis of lysosome-related organelles complex 1) | BLOC1S1 | BLOC1S1-RDH5 | BLOC1S2 | BLOC1S3 | BLOC1S4 | BLOC1S5 | BLOC1S5-TXNDC5 | BLOC1S6 | BLTP1 | BLTP2 | BLTP3A | BLTP3B | BLVRA | BLVRB | BLZF1 | BMAL1 | BMAL2 | BMAL2-AS1 | BMERB1 | BMF | BMI1 | BMP1 | BMP10 | BMP15 | BMP2 | BMP2K | BMP3 | BMP4 | BMP5 | BMP6 | BMP7 | BMP8A | BMP8B | BMPER | BMPR1A | BMPR1B | BMPR1B-DT | BMPR2 | BMS1 | BMS1P1 | BMS1P10 | BMS1P14 | BMS1P15 | BMS1P17 | BMS1P18 | BMS1P2 | BMS1P20